nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2D6—breast cancer	0.125	0.389	CbGaD
Loratadine—CYP3A4—breast cancer	0.107	0.334	CbGaD
Loratadine—ABCB1—breast cancer	0.0889	0.278	CbGaD
Loratadine—CYP2C9—Anastrozole—breast cancer	0.0252	0.0539	CbGbCtD
Loratadine—CYP2C8—Lapatinib—breast cancer	0.0241	0.0516	CbGbCtD
Loratadine—ABCB1—Toremifene—breast cancer	0.0223	0.0479	CbGbCtD
Loratadine—CYP2C19—Lapatinib—breast cancer	0.0202	0.0433	CbGbCtD
Loratadine—CYP3A4—Exemestane—breast cancer	0.0193	0.0414	CbGbCtD
Loratadine—CYP2C9—Idarubicin—breast cancer	0.0191	0.0409	CbGbCtD
Loratadine—CYP2C8—Raloxifene—breast cancer	0.0182	0.0391	CbGbCtD
Loratadine—CYP2D6—Idarubicin—breast cancer	0.0174	0.0374	CbGbCtD
Loratadine—CYP3A4—Letrozole—breast cancer	0.0164	0.0352	CbGbCtD
Loratadine—ABCB1—Lapatinib—breast cancer	0.0163	0.0349	CbGbCtD
Loratadine—CYP3A4—Anastrozole—breast cancer	0.0146	0.0314	CbGbCtD
Loratadine—CYP3A4—Toremifene—breast cancer	0.0134	0.0287	CbGbCtD
Loratadine—CYP3A4—Fulvestrant—breast cancer	0.0124	0.0267	CbGbCtD
Loratadine—CYP2C8—Tamoxifen—breast cancer	0.012	0.0258	CbGbCtD
Loratadine—CYP3A4—Thiotepa—breast cancer	0.0111	0.0238	CbGbCtD
Loratadine—CYP2C9—Capecitabine—breast cancer	0.0104	0.0224	CbGbCtD
Loratadine—CYP3A4—Ixabepilone—breast cancer	0.0101	0.0217	CbGbCtD
Loratadine—CYP2C19—Tamoxifen—breast cancer	0.0101	0.0217	CbGbCtD
Loratadine—CYP3A4—Lapatinib—breast cancer	0.00976	0.0209	CbGbCtD
Loratadine—CYP2C8—Paclitaxel—breast cancer	0.00938	0.0201	CbGbCtD
Loratadine—ABCB1—Vinorelbine—breast cancer	0.00904	0.0194	CbGbCtD
Loratadine—CYP2C8—Fluorouracil—breast cancer	0.00888	0.019	CbGbCtD
Loratadine—CYP2D6—Vinorelbine—breast cancer	0.00851	0.0183	CbGbCtD
Loratadine—CYP2C9—Tamoxifen—breast cancer	0.0084	0.018	CbGbCtD
Loratadine—ABCB1—Tamoxifen—breast cancer	0.00816	0.0175	CbGbCtD
Loratadine—ABCB1—Mitoxantrone—breast cancer	0.00795	0.0171	CbGbCtD
Loratadine—CYP2D6—Tamoxifen—breast cancer	0.00769	0.0165	CbGbCtD
Loratadine—CYP3A4—Raloxifene—breast cancer	0.0074	0.0159	CbGbCtD
Loratadine—ABCB1—Gemcitabine—breast cancer	0.00703	0.0151	CbGbCtD
Loratadine—CYP2C9—Paclitaxel—breast cancer	0.00654	0.014	CbGbCtD
Loratadine—ABCB1—Paclitaxel—breast cancer	0.00635	0.0136	CbGbCtD
Loratadine—ABCB1—Irinotecan—breast cancer	0.00626	0.0134	CbGbCtD
Loratadine—CYP2C9—Fluorouracil—breast cancer	0.00619	0.0133	CbGbCtD
Loratadine—ABCB1—Vinblastine—breast cancer	0.00557	0.0119	CbGbCtD
Loratadine—CYP3A4—Vinorelbine—breast cancer	0.00541	0.0116	CbGbCtD
Loratadine—CYP2D6—Vinblastine—breast cancer	0.00525	0.0112	CbGbCtD
Loratadine—CYP3A4—Tamoxifen—breast cancer	0.00489	0.0105	CbGbCtD
Loratadine—CYP3A4—Mitoxantrone—breast cancer	0.00477	0.0102	CbGbCtD
Loratadine—ABCB1—Docetaxel—breast cancer	0.00459	0.00984	CbGbCtD
Loratadine—CYP3A4—Paclitaxel—breast cancer	0.0038	0.00816	CbGbCtD
Loratadine—CYP3A4—Irinotecan—breast cancer	0.00375	0.00805	CbGbCtD
Loratadine—ABCB1—Doxorubicin—breast cancer	0.00342	0.00734	CbGbCtD
Loratadine—CYP3A4—Vinblastine—breast cancer	0.00334	0.00715	CbGbCtD
Loratadine—ABCB1—Methotrexate—breast cancer	0.00331	0.00711	CbGbCtD
Loratadine—CYP2D6—Doxorubicin—breast cancer	0.00322	0.00691	CbGbCtD
Loratadine—CYP3A4—Docetaxel—breast cancer	0.00275	0.0059	CbGbCtD
Loratadine—CYP3A4—Doxorubicin—breast cancer	0.00205	0.0044	CbGbCtD
Loratadine—Ketotifen—PDE4D—breast cancer	0.00129	0.544	CrCbGaD
Loratadine—Desloratadine—CYP2D6—breast cancer	0.000445	0.187	CrCbGaD
Loratadine—Azatadine—CYP3A4—breast cancer	0.00032	0.135	CrCbGaD
Loratadine—Desloratadine—ABCB1—breast cancer	0.000317	0.134	CrCbGaD
Loratadine—CYP2C8—mammary gland—breast cancer	0.000249	0.0591	CbGeAlD
Loratadine—KCNH2—nipple—breast cancer	0.000225	0.0534	CbGeAlD
Loratadine—CYP2C9—mammary gland—breast cancer	0.000221	0.0525	CbGeAlD
Loratadine—HRH1—nipple—breast cancer	0.000181	0.0428	CbGeAlD
Loratadine—KCNH2—endometrium—breast cancer	0.000136	0.0323	CbGeAlD
Loratadine—KCNH2—uterus—breast cancer	0.000125	0.0297	CbGeAlD
Loratadine—CYP2C8—endometrium—breast cancer	0.000124	0.0295	CbGeAlD
Loratadine—KCNH2—pituitary gland—breast cancer	0.000123	0.0292	CbGeAlD
Loratadine—HRH1—epithelium—breast cancer	0.000122	0.0288	CbGeAlD
Loratadine—KCNH2—female reproductive system—breast cancer	0.000113	0.0267	CbGeAlD
Loratadine—CYP2C8—pituitary gland—breast cancer	0.000113	0.0267	CbGeAlD
Loratadine—KCNH2—adrenal gland—breast cancer	0.00011	0.0261	CbGeAlD
Loratadine—HRH1—endometrium—breast cancer	0.000109	0.0259	CbGeAlD
Loratadine—KCNH2—bone marrow—breast cancer	0.000106	0.0252	CbGeAlD
Loratadine—CYP2C8—female reproductive system—breast cancer	0.000103	0.0244	CbGeAlD
Loratadine—KCNH2—female gonad—breast cancer	0.000103	0.0243	CbGeAlD
Loratadine—CYP2C19—endocrine gland—breast cancer	0.0001	0.0237	CbGeAlD
Loratadine—HRH1—adipose tissue—breast cancer	9.83e-05	0.0233	CbGeAlD
Loratadine—KCNH2—endocrine gland—breast cancer	9.54e-05	0.0226	CbGeAlD
Loratadine—CYP2C9—female reproductive system—breast cancer	9.16e-05	0.0217	CbGeAlD
Loratadine—HRH1—female reproductive system—breast cancer	9.03e-05	0.0214	CbGeAlD
Loratadine—HRH1—adrenal gland—breast cancer	8.82e-05	0.0209	CbGeAlD
Loratadine—CYP2C8—endocrine gland—breast cancer	8.73e-05	0.0207	CbGeAlD
Loratadine—HRH1—female gonad—breast cancer	8.22e-05	0.0195	CbGeAlD
Loratadine—ABCB1—embryo—breast cancer	8.16e-05	0.0193	CbGeAlD
Loratadine—CYP2C9—endocrine gland—breast cancer	7.75e-05	0.0184	CbGeAlD
Loratadine—Myalgia—Docetaxel—breast cancer	7.73e-05	0.000527	CcSEcCtD
Loratadine—Chest pain—Docetaxel—breast cancer	7.73e-05	0.000527	CcSEcCtD
Loratadine—Loss of consciousness—Capecitabine—breast cancer	7.72e-05	0.000526	CcSEcCtD
Loratadine—Nausea—Vinorelbine—breast cancer	7.72e-05	0.000526	CcSEcCtD
Loratadine—Dyspepsia—Paclitaxel—breast cancer	7.69e-05	0.000524	CcSEcCtD
Loratadine—Asthenia—Mitoxantrone—breast cancer	7.69e-05	0.000524	CcSEcCtD
Loratadine—Asthenia—Irinotecan—breast cancer	7.69e-05	0.000524	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	7.67e-05	0.000523	CcSEcCtD
Loratadine—Cough—Capecitabine—breast cancer	7.67e-05	0.000523	CcSEcCtD
Loratadine—HRH1—endocrine gland—breast cancer	7.65e-05	0.0181	CbGeAlD
Loratadine—Hypertension—Capecitabine—breast cancer	7.59e-05	0.000517	CcSEcCtD
Loratadine—Dry mouth—Docetaxel—breast cancer	7.56e-05	0.000515	CcSEcCtD
Loratadine—Gastrointestinal disorder—Paclitaxel—breast cancer	7.54e-05	0.000514	CcSEcCtD
Loratadine—Fatigue—Paclitaxel—breast cancer	7.53e-05	0.000514	CcSEcCtD
Loratadine—Pollakiuria—Doxorubicin—breast cancer	7.51e-05	0.000512	CcSEcCtD
Loratadine—Asthenia—Gemcitabine—breast cancer	7.49e-05	0.00051	CcSEcCtD
Loratadine—Chest pain—Capecitabine—breast cancer	7.48e-05	0.00051	CcSEcCtD
Loratadine—Myalgia—Capecitabine—breast cancer	7.48e-05	0.00051	CcSEcCtD
Loratadine—Pain—Paclitaxel—breast cancer	7.47e-05	0.000509	CcSEcCtD
Loratadine—Constipation—Paclitaxel—breast cancer	7.47e-05	0.000509	CcSEcCtD
Loratadine—Pharyngitis—Methotrexate—breast cancer	7.46e-05	0.000508	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	7.43e-05	0.000506	CcSEcCtD
Loratadine—Hepatobiliary disease—Epirubicin—breast cancer	7.41e-05	0.000505	CcSEcCtD
Loratadine—Anaphylactic shock—Docetaxel—breast cancer	7.41e-05	0.000505	CcSEcCtD
Loratadine—Discomfort—Capecitabine—breast cancer	7.39e-05	0.000504	CcSEcCtD
Loratadine—Epistaxis—Epirubicin—breast cancer	7.39e-05	0.000504	CcSEcCtD
Loratadine—Nausea—Thiotepa—breast cancer	7.37e-05	0.000502	CcSEcCtD
Loratadine—Diarrhoea—Irinotecan—breast cancer	7.33e-05	0.0005	CcSEcCtD
Loratadine—Diarrhoea—Mitoxantrone—breast cancer	7.33e-05	0.0005	CcSEcCtD
Loratadine—Dry mouth—Capecitabine—breast cancer	7.32e-05	0.000499	CcSEcCtD
Loratadine—Shock—Docetaxel—breast cancer	7.29e-05	0.000497	CcSEcCtD
Loratadine—Nervous system disorder—Docetaxel—breast cancer	7.26e-05	0.000495	CcSEcCtD
Loratadine—Drowsiness—Doxorubicin—breast cancer	7.25e-05	0.000494	CcSEcCtD
Loratadine—Tachycardia—Docetaxel—breast cancer	7.23e-05	0.000493	CcSEcCtD
Loratadine—Feeling abnormal—Paclitaxel—breast cancer	7.2e-05	0.000491	CcSEcCtD
Loratadine—Skin disorder—Docetaxel—breast cancer	7.19e-05	0.00049	CcSEcCtD
Loratadine—Gastrointestinal pain—Paclitaxel—breast cancer	7.15e-05	0.000487	CcSEcCtD
Loratadine—Diarrhoea—Gemcitabine—breast cancer	7.14e-05	0.000487	CcSEcCtD
Loratadine—Dizziness—Irinotecan—breast cancer	7.09e-05	0.000483	CcSEcCtD
Loratadine—Shock—Capecitabine—breast cancer	7.06e-05	0.000481	CcSEcCtD
Loratadine—Nervous system disorder—Capecitabine—breast cancer	7.03e-05	0.000479	CcSEcCtD
Loratadine—Diarrhoea—Fluorouracil—breast cancer	7.02e-05	0.000479	CcSEcCtD
Loratadine—Tinnitus—Methotrexate—breast cancer	7.01e-05	0.000478	CcSEcCtD
Loratadine—Tachycardia—Capecitabine—breast cancer	7e-05	0.000477	CcSEcCtD
Loratadine—CYP3A4—female reproductive system—breast cancer	6.99e-05	0.0166	CbGeAlD
Loratadine—Pharyngitis—Epirubicin—breast cancer	6.98e-05	0.000476	CcSEcCtD
Loratadine—Skin disorder—Capecitabine—breast cancer	6.97e-05	0.000475	CcSEcCtD
Loratadine—Hypotension—Docetaxel—breast cancer	6.92e-05	0.000472	CcSEcCtD
Loratadine—Abdominal pain—Paclitaxel—breast cancer	6.91e-05	0.000471	CcSEcCtD
Loratadine—Body temperature increased—Paclitaxel—breast cancer	6.91e-05	0.000471	CcSEcCtD
Loratadine—CYP2D6—female reproductive system—breast cancer	6.87e-05	0.0163	CbGeAlD
Loratadine—Hepatobiliary disease—Doxorubicin—breast cancer	6.85e-05	0.000467	CcSEcCtD
Loratadine—Epistaxis—Doxorubicin—breast cancer	6.84e-05	0.000466	CcSEcCtD
Loratadine—Vomiting—Mitoxantrone—breast cancer	6.81e-05	0.000464	CcSEcCtD
Loratadine—Vomiting—Irinotecan—breast cancer	6.81e-05	0.000464	CcSEcCtD
Loratadine—Immune system disorder—Methotrexate—breast cancer	6.79e-05	0.000463	CcSEcCtD
Loratadine—Dizziness—Fluorouracil—breast cancer	6.79e-05	0.000463	CcSEcCtD
Loratadine—Rash—Mitoxantrone—breast cancer	6.76e-05	0.000461	CcSEcCtD
Loratadine—Rash—Irinotecan—breast cancer	6.76e-05	0.000461	CcSEcCtD
Loratadine—Dermatitis—Irinotecan—breast cancer	6.75e-05	0.00046	CcSEcCtD
Loratadine—Dermatitis—Mitoxantrone—breast cancer	6.75e-05	0.00046	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Docetaxel—breast cancer	6.75e-05	0.00046	CcSEcCtD
Loratadine—Headache—Mitoxantrone—breast cancer	6.71e-05	0.000458	CcSEcCtD
Loratadine—Headache—Irinotecan—breast cancer	6.71e-05	0.000458	CcSEcCtD
Loratadine—Hypotension—Capecitabine—breast cancer	6.7e-05	0.000457	CcSEcCtD
Loratadine—Insomnia—Docetaxel—breast cancer	6.7e-05	0.000457	CcSEcCtD
Loratadine—ABCB1—epithelium—breast cancer	6.66e-05	0.0158	CbGeAlD
Loratadine—Paraesthesia—Docetaxel—breast cancer	6.65e-05	0.000453	CcSEcCtD
Loratadine—Alopecia—Methotrexate—breast cancer	6.64e-05	0.000453	CcSEcCtD
Loratadine—Vomiting—Gemcitabine—breast cancer	6.64e-05	0.000452	CcSEcCtD
Loratadine—KCNH2—lymph node—breast cancer	6.59e-05	0.0156	CbGeAlD
Loratadine—Somnolence—Docetaxel—breast cancer	6.58e-05	0.000449	CcSEcCtD
Loratadine—Rash—Gemcitabine—breast cancer	6.58e-05	0.000449	CcSEcCtD
Loratadine—Dermatitis—Gemcitabine—breast cancer	6.57e-05	0.000448	CcSEcCtD
Loratadine—Tinnitus—Epirubicin—breast cancer	6.56e-05	0.000447	CcSEcCtD
Loratadine—Headache—Gemcitabine—breast cancer	6.54e-05	0.000446	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Capecitabine—breast cancer	6.53e-05	0.000445	CcSEcCtD
Loratadine—Vomiting—Fluorouracil—breast cancer	6.53e-05	0.000445	CcSEcCtD
Loratadine—Dyspepsia—Docetaxel—breast cancer	6.52e-05	0.000444	CcSEcCtD
Loratadine—Insomnia—Capecitabine—breast cancer	6.49e-05	0.000442	CcSEcCtD
Loratadine—Rash—Fluorouracil—breast cancer	6.47e-05	0.000441	CcSEcCtD
Loratadine—Dermatitis—Fluorouracil—breast cancer	6.46e-05	0.000441	CcSEcCtD
Loratadine—Pharyngitis—Doxorubicin—breast cancer	6.46e-05	0.00044	CcSEcCtD
Loratadine—Paraesthesia—Capecitabine—breast cancer	6.44e-05	0.000439	CcSEcCtD
Loratadine—Headache—Fluorouracil—breast cancer	6.43e-05	0.000438	CcSEcCtD
Loratadine—Dysgeusia—Methotrexate—breast cancer	6.41e-05	0.000437	CcSEcCtD
Loratadine—Gastrointestinal disorder—Docetaxel—breast cancer	6.39e-05	0.000436	CcSEcCtD
Loratadine—Fatigue—Docetaxel—breast cancer	6.39e-05	0.000435	CcSEcCtD
Loratadine—Nausea—Mitoxantrone—breast cancer	6.36e-05	0.000434	CcSEcCtD
Loratadine—Nausea—Irinotecan—breast cancer	6.36e-05	0.000434	CcSEcCtD
Loratadine—Immune system disorder—Epirubicin—breast cancer	6.35e-05	0.000433	CcSEcCtD
Loratadine—Pain—Docetaxel—breast cancer	6.33e-05	0.000432	CcSEcCtD
Loratadine—Constipation—Docetaxel—breast cancer	6.33e-05	0.000432	CcSEcCtD
Loratadine—Dyspepsia—Capecitabine—breast cancer	6.31e-05	0.00043	CcSEcCtD
Loratadine—Arrhythmia—Epirubicin—breast cancer	6.28e-05	0.000428	CcSEcCtD
Loratadine—Asthenia—Paclitaxel—breast cancer	6.27e-05	0.000427	CcSEcCtD
Loratadine—CYP2D6—female gonad—breast cancer	6.25e-05	0.0148	CbGeAlD
Loratadine—Alopecia—Epirubicin—breast cancer	6.21e-05	0.000424	CcSEcCtD
Loratadine—Nausea—Gemcitabine—breast cancer	6.2e-05	0.000423	CcSEcCtD
Loratadine—Gastrointestinal disorder—Capecitabine—breast cancer	6.19e-05	0.000422	CcSEcCtD
Loratadine—Fatigue—Capecitabine—breast cancer	6.18e-05	0.000421	CcSEcCtD
Loratadine—Pain—Capecitabine—breast cancer	6.13e-05	0.000418	CcSEcCtD
Loratadine—Constipation—Capecitabine—breast cancer	6.13e-05	0.000418	CcSEcCtD
Loratadine—Feeling abnormal—Docetaxel—breast cancer	6.1e-05	0.000416	CcSEcCtD
Loratadine—Nausea—Fluorouracil—breast cancer	6.1e-05	0.000416	CcSEcCtD
Loratadine—Ill-defined disorder—Methotrexate—breast cancer	6.07e-05	0.000414	CcSEcCtD
Loratadine—Tinnitus—Doxorubicin—breast cancer	6.07e-05	0.000414	CcSEcCtD
Loratadine—Gastrointestinal pain—Docetaxel—breast cancer	6.06e-05	0.000413	CcSEcCtD
Loratadine—Tension—Epirubicin—breast cancer	6.01e-05	0.000409	CcSEcCtD
Loratadine—Dysgeusia—Epirubicin—breast cancer	5.99e-05	0.000409	CcSEcCtD
Loratadine—Diarrhoea—Paclitaxel—breast cancer	5.98e-05	0.000408	CcSEcCtD
Loratadine—ABCB1—endometrium—breast cancer	5.97e-05	0.0141	CbGeAlD
Loratadine—Nervousness—Epirubicin—breast cancer	5.95e-05	0.000405	CcSEcCtD
Loratadine—CYP3A4—endocrine gland—breast cancer	5.91e-05	0.014	CbGeAlD
Loratadine—Feeling abnormal—Capecitabine—breast cancer	5.91e-05	0.000403	CcSEcCtD
Loratadine—Malaise—Methotrexate—breast cancer	5.9e-05	0.000402	CcSEcCtD
Loratadine—Immune system disorder—Doxorubicin—breast cancer	5.88e-05	0.000401	CcSEcCtD
Loratadine—Gastrointestinal pain—Capecitabine—breast cancer	5.86e-05	0.0004	CcSEcCtD
Loratadine—Body temperature increased—Docetaxel—breast cancer	5.86e-05	0.000399	CcSEcCtD
Loratadine—Abdominal pain—Docetaxel—breast cancer	5.86e-05	0.000399	CcSEcCtD
Loratadine—CYP2D6—endocrine gland—breast cancer	5.82e-05	0.0138	CbGeAlD
Loratadine—Arrhythmia—Doxorubicin—breast cancer	5.81e-05	0.000396	CcSEcCtD
Loratadine—Dizziness—Paclitaxel—breast cancer	5.78e-05	0.000394	CcSEcCtD
Loratadine—Alopecia—Doxorubicin—breast cancer	5.75e-05	0.000392	CcSEcCtD
Loratadine—Cough—Methotrexate—breast cancer	5.71e-05	0.000389	CcSEcCtD
Loratadine—Ill-defined disorder—Epirubicin—breast cancer	5.68e-05	0.000387	CcSEcCtD
Loratadine—Body temperature increased—Capecitabine—breast cancer	5.67e-05	0.000386	CcSEcCtD
Loratadine—Abdominal pain—Capecitabine—breast cancer	5.67e-05	0.000386	CcSEcCtD
Loratadine—Agitation—Epirubicin—breast cancer	5.63e-05	0.000383	CcSEcCtD
Loratadine—Myalgia—Methotrexate—breast cancer	5.57e-05	0.00038	CcSEcCtD
Loratadine—Chest pain—Methotrexate—breast cancer	5.57e-05	0.00038	CcSEcCtD
Loratadine—Tension—Doxorubicin—breast cancer	5.56e-05	0.000379	CcSEcCtD
Loratadine—Vomiting—Paclitaxel—breast cancer	5.56e-05	0.000379	CcSEcCtD
Loratadine—Dysgeusia—Doxorubicin—breast cancer	5.55e-05	0.000378	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.53e-05	0.000377	CcSEcCtD
Loratadine—Malaise—Epirubicin—breast cancer	5.52e-05	0.000376	CcSEcCtD
Loratadine—Rash—Paclitaxel—breast cancer	5.51e-05	0.000376	CcSEcCtD
Loratadine—Dermatitis—Paclitaxel—breast cancer	5.5e-05	0.000375	CcSEcCtD
Loratadine—Discomfort—Methotrexate—breast cancer	5.5e-05	0.000375	CcSEcCtD
Loratadine—Nervousness—Doxorubicin—breast cancer	5.5e-05	0.000375	CcSEcCtD
Loratadine—ABCB1—uterus—breast cancer	5.5e-05	0.013	CbGeAlD
Loratadine—Syncope—Epirubicin—breast cancer	5.49e-05	0.000374	CcSEcCtD
Loratadine—Headache—Paclitaxel—breast cancer	5.47e-05	0.000373	CcSEcCtD
Loratadine—Palpitations—Epirubicin—breast cancer	5.41e-05	0.000369	CcSEcCtD
Loratadine—ABCB1—pituitary gland—breast cancer	5.4e-05	0.0128	CbGeAlD
Loratadine—Loss of consciousness—Epirubicin—breast cancer	5.38e-05	0.000367	CcSEcCtD
Loratadine—ABCB1—adipose tissue—breast cancer	5.38e-05	0.0128	CbGeAlD
Loratadine—Cough—Epirubicin—breast cancer	5.34e-05	0.000364	CcSEcCtD
Loratadine—Anaphylactic shock—Methotrexate—breast cancer	5.34e-05	0.000364	CcSEcCtD
Loratadine—Asthenia—Docetaxel—breast cancer	5.31e-05	0.000362	CcSEcCtD
Loratadine—Hypertension—Epirubicin—breast cancer	5.29e-05	0.00036	CcSEcCtD
Loratadine—HRH1—lymph node—breast cancer	5.28e-05	0.0125	CbGeAlD
Loratadine—Ill-defined disorder—Doxorubicin—breast cancer	5.26e-05	0.000358	CcSEcCtD
Loratadine—Nervous system disorder—Methotrexate—breast cancer	5.24e-05	0.000357	CcSEcCtD
Loratadine—Chest pain—Epirubicin—breast cancer	5.21e-05	0.000355	CcSEcCtD
Loratadine—Myalgia—Epirubicin—breast cancer	5.21e-05	0.000355	CcSEcCtD
Loratadine—Agitation—Doxorubicin—breast cancer	5.21e-05	0.000355	CcSEcCtD
Loratadine—Nausea—Paclitaxel—breast cancer	5.19e-05	0.000354	CcSEcCtD
Loratadine—Skin disorder—Methotrexate—breast cancer	5.19e-05	0.000353	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.18e-05	0.000353	CcSEcCtD
Loratadine—Discomfort—Epirubicin—breast cancer	5.15e-05	0.000351	CcSEcCtD
Loratadine—Asthenia—Capecitabine—breast cancer	5.15e-05	0.000351	CcSEcCtD
Loratadine—Malaise—Doxorubicin—breast cancer	5.11e-05	0.000348	CcSEcCtD
Loratadine—Dry mouth—Epirubicin—breast cancer	5.1e-05	0.000347	CcSEcCtD
Loratadine—Syncope—Doxorubicin—breast cancer	5.08e-05	0.000346	CcSEcCtD
Loratadine—Diarrhoea—Docetaxel—breast cancer	5.07e-05	0.000345	CcSEcCtD
Loratadine—Palpitations—Doxorubicin—breast cancer	5.01e-05	0.000341	CcSEcCtD
Loratadine—Anaphylactic shock—Epirubicin—breast cancer	5e-05	0.000341	CcSEcCtD
Loratadine—Hypotension—Methotrexate—breast cancer	4.99e-05	0.00034	CcSEcCtD
Loratadine—Loss of consciousness—Doxorubicin—breast cancer	4.98e-05	0.000339	CcSEcCtD
Loratadine—ABCB1—female reproductive system—breast cancer	4.94e-05	0.0117	CbGeAlD
Loratadine—Cough—Doxorubicin—breast cancer	4.94e-05	0.000337	CcSEcCtD
Loratadine—Shock—Epirubicin—breast cancer	4.92e-05	0.000335	CcSEcCtD
Loratadine—Diarrhoea—Capecitabine—breast cancer	4.91e-05	0.000334	CcSEcCtD
Loratadine—Nervous system disorder—Epirubicin—breast cancer	4.9e-05	0.000334	CcSEcCtD
Loratadine—Dizziness—Docetaxel—breast cancer	4.9e-05	0.000334	CcSEcCtD
Loratadine—Hypertension—Doxorubicin—breast cancer	4.89e-05	0.000333	CcSEcCtD
Loratadine—Tachycardia—Epirubicin—breast cancer	4.88e-05	0.000332	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Methotrexate—breast cancer	4.86e-05	0.000332	CcSEcCtD
Loratadine—Skin disorder—Epirubicin—breast cancer	4.85e-05	0.000331	CcSEcCtD
Loratadine—Insomnia—Methotrexate—breast cancer	4.83e-05	0.000329	CcSEcCtD
Loratadine—ABCB1—adrenal gland—breast cancer	4.83e-05	0.0114	CbGeAlD
Loratadine—Myalgia—Doxorubicin—breast cancer	4.82e-05	0.000329	CcSEcCtD
Loratadine—Chest pain—Doxorubicin—breast cancer	4.82e-05	0.000329	CcSEcCtD
Loratadine—Paraesthesia—Methotrexate—breast cancer	4.79e-05	0.000327	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.79e-05	0.000326	CcSEcCtD
Loratadine—Discomfort—Doxorubicin—breast cancer	4.76e-05	0.000325	CcSEcCtD
Loratadine—Somnolence—Methotrexate—breast cancer	4.75e-05	0.000324	CcSEcCtD
Loratadine—Dizziness—Capecitabine—breast cancer	4.74e-05	0.000323	CcSEcCtD
Loratadine—Dry mouth—Doxorubicin—breast cancer	4.72e-05	0.000321	CcSEcCtD
Loratadine—Vomiting—Docetaxel—breast cancer	4.71e-05	0.000321	CcSEcCtD
Loratadine—Dyspepsia—Methotrexate—breast cancer	4.7e-05	0.00032	CcSEcCtD
Loratadine—Rash—Docetaxel—breast cancer	4.67e-05	0.000318	CcSEcCtD
Loratadine—Hypotension—Epirubicin—breast cancer	4.67e-05	0.000318	CcSEcCtD
Loratadine—ABCB1—bone marrow—breast cancer	4.67e-05	0.0111	CbGeAlD
Loratadine—Dermatitis—Docetaxel—breast cancer	4.67e-05	0.000318	CcSEcCtD
Loratadine—Headache—Docetaxel—breast cancer	4.64e-05	0.000316	CcSEcCtD
Loratadine—Anaphylactic shock—Doxorubicin—breast cancer	4.62e-05	0.000315	CcSEcCtD
Loratadine—Gastrointestinal disorder—Methotrexate—breast cancer	4.61e-05	0.000314	CcSEcCtD
Loratadine—Fatigue—Methotrexate—breast cancer	4.6e-05	0.000314	CcSEcCtD
Loratadine—Pain—Methotrexate—breast cancer	4.57e-05	0.000311	CcSEcCtD
Loratadine—Vomiting—Capecitabine—breast cancer	4.56e-05	0.000311	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Epirubicin—breast cancer	4.55e-05	0.00031	CcSEcCtD
Loratadine—Shock—Doxorubicin—breast cancer	4.55e-05	0.00031	CcSEcCtD
Loratadine—Nervous system disorder—Doxorubicin—breast cancer	4.53e-05	0.000309	CcSEcCtD
Loratadine—Rash—Capecitabine—breast cancer	4.52e-05	0.000308	CcSEcCtD
Loratadine—Insomnia—Epirubicin—breast cancer	4.52e-05	0.000308	CcSEcCtD
Loratadine—Dermatitis—Capecitabine—breast cancer	4.52e-05	0.000308	CcSEcCtD
Loratadine—Tachycardia—Doxorubicin—breast cancer	4.51e-05	0.000308	CcSEcCtD
Loratadine—ABCB1—female gonad—breast cancer	4.5e-05	0.0107	CbGeAlD
Loratadine—Headache—Capecitabine—breast cancer	4.49e-05	0.000306	CcSEcCtD
Loratadine—Skin disorder—Doxorubicin—breast cancer	4.49e-05	0.000306	CcSEcCtD
Loratadine—Paraesthesia—Epirubicin—breast cancer	4.49e-05	0.000306	CcSEcCtD
Loratadine—Somnolence—Epirubicin—breast cancer	4.44e-05	0.000303	CcSEcCtD
Loratadine—Nausea—Docetaxel—breast cancer	4.4e-05	0.0003	CcSEcCtD
Loratadine—Feeling abnormal—Methotrexate—breast cancer	4.4e-05	0.0003	CcSEcCtD
Loratadine—Dyspepsia—Epirubicin—breast cancer	4.4e-05	0.0003	CcSEcCtD
Loratadine—Gastrointestinal pain—Methotrexate—breast cancer	4.37e-05	0.000298	CcSEcCtD
Loratadine—Hypotension—Doxorubicin—breast cancer	4.32e-05	0.000294	CcSEcCtD
Loratadine—Gastrointestinal disorder—Epirubicin—breast cancer	4.31e-05	0.000294	CcSEcCtD
Loratadine—Fatigue—Epirubicin—breast cancer	4.31e-05	0.000294	CcSEcCtD
Loratadine—Pain—Epirubicin—breast cancer	4.27e-05	0.000291	CcSEcCtD
Loratadine—Constipation—Epirubicin—breast cancer	4.27e-05	0.000291	CcSEcCtD
Loratadine—Nausea—Capecitabine—breast cancer	4.26e-05	0.00029	CcSEcCtD
Loratadine—Abdominal pain—Methotrexate—breast cancer	4.22e-05	0.000288	CcSEcCtD
Loratadine—Body temperature increased—Methotrexate—breast cancer	4.22e-05	0.000288	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.21e-05	0.000287	CcSEcCtD
Loratadine—ABCB1—endocrine gland—breast cancer	4.18e-05	0.00992	CbGeAlD
Loratadine—Insomnia—Doxorubicin—breast cancer	4.18e-05	0.000285	CcSEcCtD
Loratadine—Paraesthesia—Doxorubicin—breast cancer	4.15e-05	0.000283	CcSEcCtD
Loratadine—Feeling abnormal—Epirubicin—breast cancer	4.12e-05	0.000281	CcSEcCtD
Loratadine—Somnolence—Doxorubicin—breast cancer	4.11e-05	0.00028	CcSEcCtD
Loratadine—Gastrointestinal pain—Epirubicin—breast cancer	4.09e-05	0.000278	CcSEcCtD
Loratadine—Dyspepsia—Doxorubicin—breast cancer	4.07e-05	0.000277	CcSEcCtD
Loratadine—Gastrointestinal disorder—Doxorubicin—breast cancer	3.99e-05	0.000272	CcSEcCtD
Loratadine—Fatigue—Doxorubicin—breast cancer	3.99e-05	0.000272	CcSEcCtD
Loratadine—Pain—Doxorubicin—breast cancer	3.95e-05	0.000269	CcSEcCtD
Loratadine—Constipation—Doxorubicin—breast cancer	3.95e-05	0.000269	CcSEcCtD
Loratadine—Body temperature increased—Epirubicin—breast cancer	3.95e-05	0.000269	CcSEcCtD
Loratadine—Abdominal pain—Epirubicin—breast cancer	3.95e-05	0.000269	CcSEcCtD
Loratadine—Asthenia—Methotrexate—breast cancer	3.83e-05	0.000261	CcSEcCtD
Loratadine—Feeling abnormal—Doxorubicin—breast cancer	3.81e-05	0.00026	CcSEcCtD
Loratadine—Gastrointestinal pain—Doxorubicin—breast cancer	3.78e-05	0.000258	CcSEcCtD
Loratadine—Abdominal pain—Doxorubicin—breast cancer	3.65e-05	0.000249	CcSEcCtD
Loratadine—Body temperature increased—Doxorubicin—breast cancer	3.65e-05	0.000249	CcSEcCtD
Loratadine—Diarrhoea—Methotrexate—breast cancer	3.65e-05	0.000249	CcSEcCtD
Loratadine—Asthenia—Epirubicin—breast cancer	3.58e-05	0.000244	CcSEcCtD
Loratadine—Dizziness—Methotrexate—breast cancer	3.53e-05	0.000241	CcSEcCtD
Loratadine—Diarrhoea—Epirubicin—breast cancer	3.42e-05	0.000233	CcSEcCtD
Loratadine—Vomiting—Methotrexate—breast cancer	3.39e-05	0.000231	CcSEcCtD
Loratadine—Rash—Methotrexate—breast cancer	3.37e-05	0.000229	CcSEcCtD
Loratadine—Dermatitis—Methotrexate—breast cancer	3.36e-05	0.000229	CcSEcCtD
Loratadine—Headache—Methotrexate—breast cancer	3.34e-05	0.000228	CcSEcCtD
Loratadine—Asthenia—Doxorubicin—breast cancer	3.32e-05	0.000226	CcSEcCtD
Loratadine—Dizziness—Epirubicin—breast cancer	3.3e-05	0.000225	CcSEcCtD
Loratadine—Vomiting—Epirubicin—breast cancer	3.18e-05	0.000217	CcSEcCtD
Loratadine—Nausea—Methotrexate—breast cancer	3.17e-05	0.000216	CcSEcCtD
Loratadine—Diarrhoea—Doxorubicin—breast cancer	3.16e-05	0.000216	CcSEcCtD
Loratadine—Rash—Epirubicin—breast cancer	3.15e-05	0.000215	CcSEcCtD
Loratadine—Dermatitis—Epirubicin—breast cancer	3.15e-05	0.000215	CcSEcCtD
Loratadine—Headache—Epirubicin—breast cancer	3.13e-05	0.000213	CcSEcCtD
Loratadine—Dizziness—Doxorubicin—breast cancer	3.06e-05	0.000208	CcSEcCtD
Loratadine—Nausea—Epirubicin—breast cancer	2.97e-05	0.000202	CcSEcCtD
Loratadine—Vomiting—Doxorubicin—breast cancer	2.94e-05	0.0002	CcSEcCtD
Loratadine—Rash—Doxorubicin—breast cancer	2.91e-05	0.000199	CcSEcCtD
Loratadine—Dermatitis—Doxorubicin—breast cancer	2.91e-05	0.000199	CcSEcCtD
Loratadine—Headache—Doxorubicin—breast cancer	2.9e-05	0.000197	CcSEcCtD
Loratadine—ABCB1—lymph node—breast cancer	2.89e-05	0.00686	CbGeAlD
Loratadine—Nausea—Doxorubicin—breast cancer	2.75e-05	0.000187	CcSEcCtD
Loratadine—ABCB1—Metabolism—HSP90AA1—breast cancer	4.29e-06	7.15e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NCOA1—breast cancer	4.28e-06	7.12e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ERBB3—breast cancer	4.26e-06	7.11e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SLC2A1—breast cancer	4.26e-06	7.1e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NQO1—breast cancer	4.26e-06	7.1e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGFR2—breast cancer	4.26e-06	7.1e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—STK11—breast cancer	4.21e-06	7.02e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP19A1—breast cancer	4.21e-06	7.02e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP3A4—breast cancer	4.19e-06	6.99e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.17e-06	6.95e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NCOA1—breast cancer	4.17e-06	6.95e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP3A4—breast cancer	4.16e-06	6.93e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.14e-06	6.89e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ABCB1—breast cancer	4.13e-06	6.89e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP1B1—breast cancer	4.12e-06	6.87e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—STK11—breast cancer	4.11e-06	6.85e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP19A1—breast cancer	4.11e-06	6.85e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL2—breast cancer	4.1e-06	6.84e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TERT—breast cancer	4.09e-06	6.81e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP1B1—breast cancer	4.09e-06	6.81e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—TYMS—breast cancer	4.06e-06	6.77e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HSP90AA1—breast cancer	4.04e-06	6.74e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PLA2G4A—breast cancer	4.01e-06	6.69e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NCOR1—breast cancer	4.01e-06	6.69e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTM1—breast cancer	4.01e-06	6.69e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HSP90AA1—breast cancer	4.01e-06	6.68e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGFR1—breast cancer	3.97e-06	6.61e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.96e-06	6.59e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NCOA1—breast cancer	3.93e-06	6.55e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—COMT—breast cancer	3.92e-06	6.53e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HIF1A—breast cancer	3.91e-06	6.51e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTP1—breast cancer	3.9e-06	6.5e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NCOA1—breast cancer	3.9e-06	6.5e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—STK11—breast cancer	3.88e-06	6.46e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP19A1—breast cancer	3.88e-06	6.46e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HMOX1—breast cancer	3.84e-06	6.41e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GPX1—breast cancer	3.84e-06	6.41e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP19A1—breast cancer	3.84e-06	6.4e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—STK11—breast cancer	3.84e-06	6.4e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ITPR1—breast cancer	3.84e-06	6.39e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—DPYD—breast cancer	3.82e-06	6.37e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MED12—breast cancer	3.82e-06	6.37e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—COMT—breast cancer	3.82e-06	6.37e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—LEP—breast cancer	3.82e-06	6.36e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTP1—breast cancer	3.81e-06	6.34e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP1A1—breast cancer	3.8e-06	6.34e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CAV1—breast cancer	3.78e-06	6.3e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ERCC2—breast cancer	3.77e-06	6.29e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALDOA—breast cancer	3.77e-06	6.27e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HMOX1—breast cancer	3.75e-06	6.25e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ITPR1—breast cancer	3.74e-06	6.24e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KDR—breast cancer	3.74e-06	6.23e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ABCB1—breast cancer	3.69e-06	6.15e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NCOA3—breast cancer	3.66e-06	6.09e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ESR1—breast cancer	3.64e-06	6.07e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC2A2—breast cancer	3.63e-06	6.05e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—TYMS—breast cancer	3.62e-06	6.04e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.61e-06	6.01e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—COMT—breast cancer	3.6e-06	6e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FN1—breast cancer	3.6e-06	6e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTP1—breast cancer	3.59e-06	5.98e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NCOR1—breast cancer	3.58e-06	5.97e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PLA2G4A—breast cancer	3.58e-06	5.97e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTM1—breast cancer	3.58e-06	5.97e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—COMT—breast cancer	3.57e-06	5.95e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CPT1A—breast cancer	3.56e-06	5.93e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCG2—breast cancer	3.56e-06	5.93e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTR—breast cancer	3.56e-06	5.93e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NFKBIA—breast cancer	3.56e-06	5.93e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTP1—breast cancer	3.55e-06	5.92e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—MTHFR—breast cancer	3.55e-06	5.91e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—TYMS—breast cancer	3.54e-06	5.89e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HMOX1—breast cancer	3.54e-06	5.89e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ITPR1—breast cancer	3.53e-06	5.88e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOTCH1—breast cancer	3.52e-06	5.87e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HMOX1—breast cancer	3.51e-06	5.84e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ITPR1—breast cancer	3.5e-06	5.83e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NCOR1—breast cancer	3.5e-06	5.83e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PLA2G4A—breast cancer	3.5e-06	5.83e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTM1—breast cancer	3.5e-06	5.83e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HPGDS—breast cancer	3.49e-06	5.81e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HBA1—breast cancer	3.47e-06	5.77e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APC—breast cancer	3.44e-06	5.74e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CG—breast cancer	3.44e-06	5.74e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KIT—breast cancer	3.44e-06	5.74e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GPX1—breast cancer	3.43e-06	5.72e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EGF—breast cancer	3.4e-06	5.67e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP1A1—breast cancer	3.4e-06	5.66e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ABCB1—breast cancer	3.39e-06	5.66e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ACHE—breast cancer	3.38e-06	5.64e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTT1—breast cancer	3.38e-06	5.64e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ERCC2—breast cancer	3.37e-06	5.61e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ABCB1—breast cancer	3.36e-06	5.61e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GPX1—breast cancer	3.35e-06	5.58e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—TYMS—breast cancer	3.33e-06	5.56e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP1A1—breast cancer	3.31e-06	5.52e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—TYMS—breast cancer	3.3e-06	5.51e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—MAPK3—breast cancer	3.3e-06	5.5e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.3e-06	5.49e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTM1—breast cancer	3.3e-06	5.49e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NCOR1—breast cancer	3.3e-06	5.49e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ERCC2—breast cancer	3.29e-06	5.48e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CAV1—breast cancer	3.27e-06	5.45e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NCOR1—breast cancer	3.27e-06	5.44e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTM1—breast cancer	3.27e-06	5.44e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.27e-06	5.44e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—BRAF—breast cancer	3.24e-06	5.39e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP17A1—breast cancer	3.2e-06	5.34e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ENO1—breast cancer	3.17e-06	5.28e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS1—breast cancer	3.17e-06	5.28e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—MTHFR—breast cancer	3.17e-06	5.28e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GPX1—breast cancer	3.16e-06	5.26e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF1—breast cancer	3.15e-06	5.25e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT2—breast cancer	3.15e-06	5.25e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—EGFR—breast cancer	3.14e-06	5.23e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GPX1—breast cancer	3.13e-06	5.21e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.13e-06	5.21e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP1A1—breast cancer	3.12e-06	5.21e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2D6—breast cancer	3.11e-06	5.18e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ERCC2—breast cancer	3.1e-06	5.16e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP1A1—breast cancer	3.1e-06	5.16e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—MTHFR—breast cancer	3.09e-06	5.15e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ERCC2—breast cancer	3.07e-06	5.12e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NCOA2—breast cancer	3.05e-06	5.08e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CD—breast cancer	3.03e-06	5.04e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	3e-06	5e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SERPINE1—breast cancer	2.99e-06	4.99e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CG—breast cancer	2.98e-06	4.97e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—KRAS—breast cancer	2.96e-06	4.94e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—FASN—breast cancer	2.96e-06	4.93e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—BCHE—breast cancer	2.95e-06	4.91e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CAV1—breast cancer	2.92e-06	4.87e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—MTHFR—breast cancer	2.91e-06	4.85e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC5A5—breast cancer	2.91e-06	4.85e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—MTHFR—breast cancer	2.89e-06	4.81e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOS3—breast cancer	2.86e-06	4.76e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CAV1—breast cancer	2.85e-06	4.75e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC2A1—breast cancer	2.81e-06	4.68e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NQO1—breast cancer	2.81e-06	4.68e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.79e-06	4.65e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	2.72e-06	4.54e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MDM2—breast cancer	2.71e-06	4.52e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RAF1—breast cancer	2.7e-06	4.5e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP1B1—breast cancer	2.69e-06	4.49e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RELA—breast cancer	2.69e-06	4.48e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CAV1—breast cancer	2.69e-06	4.48e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ERBB2—breast cancer	2.67e-06	4.46e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CAV1—breast cancer	2.66e-06	4.44e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CG—breast cancer	2.66e-06	4.43e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.64e-06	4.4e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CB—breast cancer	2.64e-06	4.4e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MTOR—breast cancer	2.64e-06	4.4e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CD—breast cancer	2.62e-06	4.37e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CG—breast cancer	2.6e-06	4.33e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ALB—breast cancer	2.59e-06	4.31e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NCOA1—breast cancer	2.57e-06	4.28e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.54e-06	4.24e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CXCL8—breast cancer	2.54e-06	4.23e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—STK11—breast cancer	2.53e-06	4.22e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP19A1—breast cancer	2.53e-06	4.22e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—HRAS—breast cancer	2.52e-06	4.2e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1B—breast cancer	2.48e-06	4.13e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NOS3—breast cancer	2.47e-06	4.12e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AKT1—breast cancer	2.45e-06	4.08e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CG—breast cancer	2.45e-06	4.08e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CASP3—breast cancer	2.43e-06	4.04e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CG—breast cancer	2.43e-06	4.04e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL2—breast cancer	2.42e-06	4.04e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL6—breast cancer	2.41e-06	4.02e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCND1—breast cancer	2.36e-06	3.94e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JUN—breast cancer	2.36e-06	3.93e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—COMT—breast cancer	2.36e-06	3.93e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTP1—breast cancer	2.34e-06	3.91e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CTNNB1—breast cancer	2.34e-06	3.9e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CD—breast cancer	2.34e-06	3.9e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HMOX1—breast cancer	2.31e-06	3.85e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALB—breast cancer	2.31e-06	3.85e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ITPR1—breast cancer	2.31e-06	3.84e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MMP9—breast cancer	2.29e-06	3.82e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1A—breast cancer	2.29e-06	3.81e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CB—breast cancer	2.28e-06	3.81e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CD—breast cancer	2.28e-06	3.8e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTEN—breast cancer	2.28e-06	3.8e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS2—breast cancer	2.26e-06	3.77e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALB—breast cancer	2.25e-06	3.75e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK8—breast cancer	2.23e-06	3.72e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AKT1—breast cancer	2.22e-06	3.71e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCB1—breast cancer	2.22e-06	3.7e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NOS3—breast cancer	2.21e-06	3.68e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TYMS—breast cancer	2.18e-06	3.63e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NOS3—breast cancer	2.16e-06	3.59e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.15e-06	3.59e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NCOR1—breast cancer	2.15e-06	3.59e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTM1—breast cancer	2.15e-06	3.59e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.15e-06	3.58e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CD—breast cancer	2.13e-06	3.55e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALB—breast cancer	2.12e-06	3.54e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SRC—breast cancer	2.11e-06	3.52e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALB—breast cancer	2.1e-06	3.51e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GPX1—breast cancer	2.06e-06	3.44e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—breast cancer	2.06e-06	3.43e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP1A1—breast cancer	2.04e-06	3.4e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—STAT3—breast cancer	2.04e-06	3.4e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CB—breast cancer	2.04e-06	3.4e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NOS3—breast cancer	2.03e-06	3.38e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ERCC2—breast cancer	2.03e-06	3.38e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS2—breast cancer	2.02e-06	3.37e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NOS3—breast cancer	2.01e-06	3.36e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CB—breast cancer	1.99e-06	3.32e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTEN—breast cancer	1.97e-06	3.29e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS2—breast cancer	1.97e-06	3.29e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK3—breast cancer	1.95e-06	3.25e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTHFR—breast cancer	1.9e-06	3.17e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MYC—breast cancer	1.89e-06	3.16e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TGFB1—breast cancer	1.89e-06	3.15e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.87e-06	3.12e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CB—breast cancer	1.86e-06	3.1e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS2—breast cancer	1.86e-06	3.1e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EGFR—breast cancer	1.85e-06	3.09e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS2—breast cancer	1.84e-06	3.07e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTEN—breast cancer	1.76e-06	2.94e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CAV1—breast cancer	1.76e-06	2.93e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KRAS—breast cancer	1.75e-06	2.92e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTEN—breast cancer	1.72e-06	2.86e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTEN—breast cancer	1.62e-06	2.7e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.61e-06	2.68e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTEN—breast cancer	1.61e-06	2.68e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.6e-06	2.67e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TP53—breast cancer	1.56e-06	2.59e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HRAS—breast cancer	1.49e-06	2.48e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6—breast cancer	1.42e-06	2.37e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.41e-06	2.34e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CA—breast cancer	1.39e-06	2.32e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALB—breast cancer	1.39e-06	2.31e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NOS3—breast cancer	1.33e-06	2.21e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT1—breast cancer	1.31e-06	2.19e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CA—breast cancer	1.24e-06	2.07e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.23e-06	2.04e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS2—breast cancer	1.21e-06	2.02e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CA—breast cancer	1.21e-06	2.02e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.14e-06	1.9e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKT1—breast cancer	1.14e-06	1.9e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CA—breast cancer	1.13e-06	1.89e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTEN—breast cancer	1.06e-06	1.77e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKT1—breast cancer	1.02e-06	1.69e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKT1—breast cancer	9.91e-07	1.65e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKT1—breast cancer	9.34e-07	1.56e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKT1—breast cancer	9.26e-07	1.54e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CA—breast cancer	7.47e-07	1.25e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKT1—breast cancer	6.1e-07	1.02e-05	CbGpPWpGaD
